{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:51:24Z","timestamp":1793267484650,"version":"4.5.0"},"reference-count":221,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Congenital cytomegalovirus (cCMV) infection is the most prevalent congenital infection, affecting approximately 0.5\u20132% of newborns, and is the leading non-genetic cause of sensorineural hearing loss and neurological impairment. The most severe outcome occurs following primary maternal infection during the first trimester of pregnancy, and up to 40\u201350% of affected fetuses sustain permanent damage. Diagnosis relies on early prenatal screening through maternal serum testing, optimally performed in the first trimester, followed by confirmatory amniocentesis after 17 weeks\u2019 gestation. Prenatal imaging with ultrasound and magnetic resonance imaging (MRI) plays a critical role in the identification of fetal brain abnormalities. Prevention strategies emphasize hygiene measures aimed at reducing maternal exposure to bodily fluids of young children, particularly prior to conception and during early pregnancy. Despite progress in vaccine development, currently available ones demonstrate modest efficacy. This review presents a comprehensive summary of congenital CMV infection, addressing its epidemiology, pathogenesis, diagnostic approaches, clinical presentation, and preventive measures, with a focus on recent advances in vaccine research.<\/jats:p>","DOI":"10.3390\/vaccines13090929","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T16:05:22Z","timestamp":1756829122000},"page":"929","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Congenital Cytomegalovirus Infection: From Silent Threat to Vaccine Horizon"],"prefix":"10.3390","volume":"13","author":[{"given":"Rafaela Anna","family":"Moutsopoulou","sequence":"first","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Markou","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8588-8672","authenticated-orcid":false,"given":"Alexandra","family":"Lianou","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, General Hospital of Nikaia \u201cAgios Panteleimon\u201d, 18454 Piraeus, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0088-0775","authenticated-orcid":false,"given":"Konstantina","family":"Leontari","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4316-7305","authenticated-orcid":false,"given":"Zoi","family":"Iliodromiti","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Boutsikou","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kafalidis","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Paliatsiou","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Volaki","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8021-6191","authenticated-orcid":false,"given":"Nicoletta","family":"Iacovidou","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-0759","authenticated-orcid":false,"given":"Andreas G.","family":"Tsantes","sequence":"additional","affiliation":[{"name":"Microbiology Department, \u201cSaint Savvas\u201d Oncology Hospital, 11522 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9972-8901","authenticated-orcid":false,"given":"Rozeta","family":"Sokou","sequence":"additional","affiliation":[{"name":"Neonatal Department, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Baker, M.R., Wang, X., and Melvin, A.J. (2025). Timing of congenital cytomegalovirus diagnosis and missed opportunities. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1475121"},{"key":"ref_2","unstructured":"Akpan, U.S., and Pillarisetty, L.S. (2025). Congenital Cytomegalovirus Infection. StatPearls, StatPearls Publishing LLC."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Salom\u00e8, S., Corrado, F.R., Mazzarelli, L.L., Maruotti, G.M., Capasso, L., Blazquez-Gamero, D., and Raimondi, F. (2023). Congenital cytomegalovirus infection: The state of the art and future perspectives. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1276912"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/bdra.23601","article-title":"Cytomegalovirus infection in pregnancy","volume":"109","author":"Davis","year":"2017","journal-title":"Birth Defects Res."},{"key":"ref_5","unstructured":"Boppana, S.B., and Hui, L. (2025, May 12). Cytomegalovirus Infection in Pregnancy. Available online: https:\/\/www.uptodate.com\/contents\/cytomegalovirus-infection-in-pregnancy."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41390-023-02957-9","article-title":"Decoding human cytomegalovirus for the development of innovative diagnostics to detect congenital infection","volume":"95","author":"Lawrence","year":"2024","journal-title":"Pediatr. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","article-title":"Cytomegalovirus infection during pregnancy: State of the science","volume":"223","author":"Foulon","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/jmwh.13749","article-title":"Provider-Led Interventions to Reduce Congenital Cytomegalovirus","volume":"70","author":"Trisko","year":"2025","journal-title":"J. Midwifery Women\u2019s Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","article-title":"Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: Systematic review and meta-analysis","volume":"61","author":"Marinceu","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sokou, R., Lianou, A., Lampridou, M., Panagiotounakou, P., Kafalidis, G., Paliatsiou, S., Volaki, P., Tsantes, A.G., Boutsikou, T., and Iliodromiti, Z. (2025). Neonates at Risk: Understanding the Impact of High-Risk Pregnancies on Neonatal Health. Medicina, 61.","DOI":"10.3390\/medicina61061077"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2120736","DOI":"10.1001\/jamanetworkopen.2021.20736","article-title":"Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening: A Systematic Review and Meta-analysis","volume":"4","author":"Ssentongo","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Payne, H., and Barnabas, S. (2024). Congenital cytomegalovirus in Sub-Saharan Africa-A narrative review with practice recommendations. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1359663"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","article-title":"Congenital Cytomegalovirus infection: Advances and challenges in diagnosis, prevention and treatment","volume":"43","author":"Marsico","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.cmi.2021.09.013","article-title":"Human cytomegalovirus non-primary infection during pregnancy: Antibody response, risk factors and newborn outcome","volume":"28","author":"Zelini","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5468\/ogs.23117","article-title":"Cytomegalovirus infection during pregnancy","volume":"66","author":"Choodinatha","year":"2023","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_17","unstructured":"CDC (2025, May 11). CMV in Newborns, Available online: https:\/\/www.cdc.gov\/cytomegalovirus\/congenital-infection\/index.html."},{"key":"ref_18","unstructured":"ACOG (2015). Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy, ACOG."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/1471-0528.17966","article-title":"Congenital Cytomegalovirus Infection: Update on Screening, Diagnosis and Treatment: Scientific Impact Paper No. 56","volume":"132","author":"Khalil","year":"2025","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","article-title":"Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)","volume":"40","author":"Chatzakis","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"\u015awi\u0105tkowska-Freund, M., Bednarek, S., Sasak-Cie\u015blar, N., Koci\u0119cka, N., Powro\u017anik, P., and Waldman, A. (2025). Cytomegalovirus Seroprevalence in Northern Poland in the Population Planning Pregnancy and Pregnant Women. Viruses, 17.","DOI":"10.3390\/v17040537"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000544169","article-title":"First-Trimester Universal One-Time Serology Screening for Cytomegalovirus: A Pilot Study at Two Tertiary Referral Centers in Barcelona (Catalunya, Spain)","volume":"52","author":"Castillo","year":"2025","journal-title":"Fetal Diagn. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/CVI.00487-14","article-title":"Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy","volume":"21","author":"Prince","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Forte, E., Zhang, Z., Thorp, E.B., and Hummel, M. (2020). Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00130"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcv.2012.10.017","article-title":"Re-evaluation of the VIDAS\u00ae cytomegalovirus (CMV) IgG avidity assay: Determination of new cut-off values based on the study of kinetics of CMV-IgG maturation","volume":"56","author":"Berth","year":"2013","journal-title":"J. Clin. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10096-014-2080-4","article-title":"Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay","volume":"33","author":"Lazzarotto","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sarasini, A., Arossa, A., Zavattoni, M., Fornara, C., Lilleri, D., Spinillo, A., Baldanti, F., and Furione, M. (2021). Pitfalls in the Serological Diagnosis of Primary Human Cytomegalovirus Infection in Pregnancy Due to Different Kinetics of IgM Clearance and IgG Avidity Index Maturation. Diagnostics, 11.","DOI":"10.3390\/diagnostics11030396"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejogrb.2025.01.020","article-title":"Diagnosis and management of congenital Cytomegalovirus: Critical Appraisal of Clinical Practice Guidelines","volume":"306","author":"Sorrenti","year":"2025","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/uog.26128","article-title":"Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: Systematic review and meta-analysis","volume":"61","author":"Chatzakis","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pontes, K.F.M., Nardozza, L.M.M., Peixoto, A.B., Werner, H., Tonni, G., Granese, R., and Araujo J\u00fanior, E. (2024). Cytomegalovirus and Pregnancy: A Narrative Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020640"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/pd.5107","article-title":"Amniocentesis for prenatal diagnosis of cytomegalovirus infection: Challenging the 21 weeks\u2019 threshold","volume":"37","author":"Enders","year":"2017","journal-title":"Prenat. Diagn."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/uog.23608","article-title":"First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: Feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS","volume":"57","author":"Fourgeaud","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2024.01.037","article-title":"Counseling in fetal medicine: Congenital cytomegalovirus infection","volume":"295","author":"Rizzo","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_34","first-page":"243","article-title":"Callosal Injuries in Cytomegalovirus Fetopathy: A Neurosonographic Study","volume":"52","author":"Malinger","year":"2025","journal-title":"Fetal Diagn. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpeds.2006.11.032","article-title":"Cranial ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection","volume":"150","author":"Ancora","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100808","DOI":"10.1016\/j.modpat.2025.100808","article-title":"The Spectrum of Placental Findings of First-Trimester Cytomegalovirus Infection Related to the Presence of Symptoms in the Newborns and Stillbirths","volume":"38","author":"Montero","year":"2025","journal-title":"Mod. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hamilton, S.T., Scott, G., Naing, Z., Iwasenko, J., Hall, B., Graf, N., Arbuckle, S., Craig, M.E., and Rawlinson, W.D. (2012). Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052899"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pd.4340","article-title":"Detailed in utero ultrasound description of 30 cases of congenital cytomegalovirus infection","volume":"34","author":"Picone","year":"2014","journal-title":"Prenat. Diagn."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/aogs.15018","article-title":"Prevalence and timing of prenatal ultrasound findings in cytomegalovirus-infected pregnancies","volume":"104","author":"Lagrou","year":"2025","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bartek, V., and Beke, A. (2025). Investigation of Pre- and Postnatal Abnormalities Caused by Prenatal CMV Infection\u2014Systematic Review. Children, 12.","DOI":"10.3390\/children12050607"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/1471-0528.15935","article-title":"Refining the prognosis of fetuses infected with Cytomegalovirus in the first trimester of pregnancy by serial prenatal assessment: A single-centre retrospective study","volume":"127","author":"Millischer","year":"2020","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/pd.6731","article-title":"Follow-Up of Infants With Congenital Cytomegalovirus Following Maternal Primary Infection in the First Trimester and Normal Fetal Brain Imaging at Midgestation","volume":"45","author":"Seidenari","year":"2025","journal-title":"Prenat. Diagn."},{"key":"ref_43","first-page":"e341","article-title":"Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis","volume":"215","author":"Stirnemann","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/uog.12377","article-title":"Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging","volume":"41","author":"Lipitz","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1016\/j.ajog.2007.09.052","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A series of 238 cytomegalovirus primary infections during pregnancy: Description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat. Diagn."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-0528.2008.01714.x","article-title":"The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus","volume":"115","author":"Benoist","year":"2008","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/S1413-86702008000100009","article-title":"Prognostic markers of symptomatic congenital cytomegalovirus infection","volume":"12","author":"Romanelli","year":"2008","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1471-0528.2010.02822.x","article-title":"Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood","volume":"118","author":"Fabbri","year":"2011","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/uog.23143","article-title":"Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: Systematic review and meta-analysis","volume":"57","author":"Buca","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cradeur, A., Jackson, A., Ware, E., Fourrier, T.L., and Mankekar, G. (2025). Congenital Cytomegalovirus (cCMV) Infection as a Leading Cause of Pediatric Hearing Loss: Review. Children, 12.","DOI":"10.3390\/children12050613"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Aldon, M.L., Raveentheran, G., Amin, Z., Chan, S.M., Aoyama, R., Tee, N., Ng, S.Y., Lee, C.K., Ng, P.G., and Low, J.M. (2025). Congenital cytomegalovirus screening in neonates born after 35 weeks gestation\u2014Is targeted screening beneficial?. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1510612"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12985-015-0281-9","article-title":"Dried blood spots PCR assays to screen congenital cytomegalovirus infection: A meta-analysis","volume":"12","author":"Wang","year":"2015","journal-title":"Virol. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2352-4642(24)00237-2","article-title":"Universal newborn screening for congenital cytomegalovirus infection","volume":"9","author":"Schleiss","year":"2025","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpeds.2017.01.047","article-title":"Newborn Dried Blood Spot Polymerase Chain Reaction to Identify Infants with Congenital Cytomegalovirus-Associated Sensorineural Hearing Loss","volume":"184","author":"Ross","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Robles, V., Weimer, K.E.D., Gehtland, L.M., and Kucera, K.S. (2023). Improved Dried Blood Spot PCR Assay for Universal Congenital Cytomegalovirus Screening in Newborns. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.04041-22"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S630","DOI":"10.1016\/j.ajog.2023.09.037","article-title":"Analysis of Dried Blood Spot and Saliva PCR Screening for Detection of Congenital Cytomegalovirus Infection Informs Implementation of a Novel Universal Newborn Screening Program","volume":"230","author":"Landers","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0009922816684596","article-title":"Positive IgM in Congenital CMV Infection","volume":"56","author":"Bilavsky","year":"2017","journal-title":"Clin. Pediatr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1386-6532(99)00016-5","article-title":"Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns","volume":"14","author":"Revello","year":"1999","journal-title":"J. Clin. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ye, L., Qian, Y., Yu, W., Guo, G., Wang, H., and Xue, X. (2020). Functional Profile of Human Cytomegalovirus Genes and Their Associated Diseases: A Review. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.02104"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Collins-McMillen, D., Buehler, J., Peppenelli, M., and Goodrum, F. (2018). Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation. Viruses, 10.","DOI":"10.3390\/v10080444"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1086\/340653","article-title":"Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts","volume":"185","author":"Emery","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat. Reviews. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Shang, Z., and Li, X. (2024). Human cytomegalovirus: Pathogenesis, prevention, and treatment. Mol. Biomed., 5.","DOI":"10.1186\/s43556-024-00226-7"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1913569","article-title":"A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection","volume":"385","author":"Hughes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJM198204223061601","article-title":"Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection","volume":"306","author":"Stagno","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_68","unstructured":"CDC (2025, May 15). Cytomegalovirus (CMV) and Congenital CMV Infection, Available online: https:\/\/www.cdc.gov\/cytomegalovirus\/about\/index.html."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1469-0691.2010.03140.x","article-title":"Transmission of cytomegalovirus via breast milk to the prematurely born infant: A systematic review","volume":"16","author":"Kurath","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hu, X., Hu, W., Sun, X., Chen, L., and Luo, X. (2021). Transmission of cytomegalovirus via breast milk in low birth weight and premature infants: A systematic review and meta-analysis. BMC Pediatr., 21.","DOI":"10.1186\/s12887-021-02984-7"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcv.2007.12.005","article-title":"Cytomegalovirus transmission to preterm infants during lactation","volume":"41","author":"Hamprecht","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1203\/01.PDR.0000143155.84802.A3","article-title":"Cytomegalovirus in Breast Milk: Reassessment of Pasteurization and Freeze-Thawing","volume":"56","author":"Forsgren","year":"2004","journal-title":"Pediatr. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/jama.2020.3138","article-title":"Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial","volume":"323","author":"Singh","year":"2020","journal-title":"JAMA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1111\/trf.15456","article-title":"Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation","volume":"59","author":"Shigemura","year":"2019","journal-title":"Transfusion"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"101282","DOI":"10.1016\/j.blre.2025.101282","article-title":"Bridging the evidence-to-practice gap: Advancing neonatal blood transfusion. A narrative review of recent guidelines","volume":"71","author":"Sokou","year":"2025","journal-title":"Blood Rev."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Sokou, R., Gounari, E.A., Lianou, A., Tsantes, A.G., Piovani, D., Bonovas, S., Iacovidou, N., and Tsantes, A.E. (2025). Rethinking Platelet and Plasma Transfusion Strategies for Neonates: Evidence, Guidelines, and Unanswered Questions. Semin. Thromb. Hemost.","DOI":"10.1055\/a-2601-9364"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00430-015-0403-4","article-title":"Cytomegalovirus immune evasion of myeloid lineage cells","volume":"204","author":"Brinkmann","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.20021522","article-title":"Dendritic cell responses to early murine cytomegalovirus infection: Subset functional specialization and differential regulation by interferon alpha\/beta","volume":"197","author":"Dalod","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nri3277","article-title":"The impact of differential antiviral immunity in children and adults","volume":"12","author":"Prendergast","year":"2012","journal-title":"Nat. reviews. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nature22795","article-title":"Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2","volume":"546","author":"McGovern","year":"2017","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1164511","article-title":"Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in Utero","volume":"322","author":"Mold","year":"2008","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1172\/JCI68989","article-title":"Differentiation and functional regulation of human fetal NK cells","volume":"123","author":"Ivarsson","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ni.2388","article-title":"TGF-\u03b2 is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy","volume":"13","author":"Marcoe","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.ai.2016.10.001","article-title":"About Training and Memory: NK-Cell Adaptation to Viral Infections","volume":"133","author":"Hammer","year":"2017","journal-title":"Adv. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/eji.201242752","article-title":"Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children","volume":"42","author":"Noyola","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Gaynor, L.M., and Colucci, F. (2017). Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00467"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Siewiera, J., El Costa, H., Tabiasco, J., Berrebi, A., Cartron, G., Bouteiller, P., Jabrane-Ferrat, N., and Jonjic, S. (2013). Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog., 9.","DOI":"10.1371\/annotation\/94476def-de2e-4a6e-b0c2-2f2d2ccae784"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"Harty","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Rudd, B.D., Venturi, V., Smith, N.L., Nzingha, K., Goldberg, E.L., Li, G., Nikolich-Zugich, J., Davenport, M.P., and Jameson, S.C. (2013). Acute neonatal infections \u2018lock-in\u2019 a suboptimal CD8+ T cell repertoire with impaired recall responses. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003572"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4049\/jimmunol.1400553","article-title":"Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life","volume":"193","author":"Smith","year":"2014","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1074-7613(04)00072-X","article-title":"IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2","volume":"20","author":"Li","year":"2004","journal-title":"Immunity"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1203\/01.PDR.0000104150.85437.FE","article-title":"Cellular immune response of fetuses to cytomegalovirus","volume":"55","author":"Ould","year":"2004","journal-title":"Pediatr. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI200317470","article-title":"Mature CD8+ T lymphocyte response to viral infection during fetal life","volume":"111","author":"Marchant","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1084\/jem.20090348","article-title":"Human cytomegalovirus elicits fetal gammadelta T cell responses in utero","volume":"207","author":"Vermijlen","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/039463201002300122","article-title":"B lymphocyte subsets and their functional activity in the early months of life","volume":"23","author":"Avanzini","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_96","first-page":"543","article-title":"Immune responses to congenital cytomegalovirus infection","volume":"20","author":"Britt","year":"2017","journal-title":"Microbes Infect."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40560-015-0107-2","article-title":"The offering of family presence during resuscitation: A systematic review and meta-analysis","volume":"3","author":"Oczkowski","year":"2015","journal-title":"J. Intensive Care"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Nigro, G., Muselli, M., and on behalf of the Congenital Cytomegalic Disease Collaborating, G. (2023). Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy. Viruses, 15.","DOI":"10.3390\/v15061376"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"297-e1","DOI":"10.1016\/j.ajog.2009.11.018","article-title":"Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population","volume":"202","author":"Yamamoto","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coviro.2014.02.004","article-title":"Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease","volume":"6","author":"Wang","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lilleri, D., Kabanova, A., Revello, M.G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D., and Gerna, G. (2013). Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059863"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000381626","article-title":"Passive Immunization against Congenital Cytomegalovirus Infection: Current State of Knowledge","volume":"95","author":"Rothenburger","year":"2015","journal-title":"Pharmacology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/jpm-2014-0071","article-title":"Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection","volume":"43","author":"Kobayashi","year":"2015","journal-title":"J. Perinat. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: Consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Scaramuzzino, F., Di Pastena, M., Chiurchiu, S., Romani, L., De Luca, M., Lucignani, G., Amodio, D., Seccia, A., Marsella, P., and Grimaldi Capitello, T. (2022). Secondary cytomegalovirus infections: How much do we still not know? Comparison of children with symptomatic congenital cytomegalovirus born to mothers with primary and secondary infection. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.885926"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2017.09.006","article-title":"Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection","volume":"96","author":"Giannattasio","year":"2017","journal-title":"J. Clin. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J. Clin. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/uog.7657","article-title":"Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection","volume":"36","author":"Lipitz","year":"2010","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e20183095","DOI":"10.1542\/peds.2018-3095","article-title":"Hearing Loss With Congenital Cytomegalovirus Infection","volume":"144","author":"Foulon","year":"2019","journal-title":"Pediatrics"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Njue, A., Coyne, C., Margulis, A.V., Wang, D., Marks, M.A., Russell, K., Das, R., and Sinha, A. (2020). The Role of Congenital Cytomegalovirus Infection in Adverse Birth Outcomes: A Review of the Potential Mechanisms. Viruses, 13.","DOI":"10.3390\/v13010020"},{"key":"ref_113","unstructured":"Demmler-Harrison, G.J. (2025, May 03). Congenital Cytomegalovirus (cCMV) Infection: Clinical Features and Diagnosis. Available online: https:\/\/www.uptodate.com\/contents\/congenital-cytomegalovirus-ccmv-infection-clinical-features-and-diagnosis."},{"key":"ref_114","first-page":"e87869","article-title":"Congenital Cytomegalovirus Pneumonitis Mimicking Childhood Interstitial Lung Disease: A Case Report and Review of Diagnostic Challenges","volume":"17","author":"Elfatih","year":"2025","journal-title":"Cureus"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Swanson, M.R., Haisley, L.D., Dobyns, W.B., and Schleiss, M.R. (2025). Beyond hearing loss: Exploring neurological and neurodevelopmental sequelae in asymptomatic congenital cytomegalovirus infection. Pediatr. Res., 1\u201312.","DOI":"10.1038\/s41390-025-04232-5"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jpids\/piaa154","article-title":"Congenital Cytomegalovirus Infection Following Second and Third Trimester Maternal Infection Is Associated With Mild Childhood Adverse Outcome Not Predicted by Prenatal Imaging","volume":"10","author":"Weisz","year":"2021","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital cytomegalovirus infection: Clinical outcome","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_120","first-page":"111","article-title":"Neurological sequelae in patients with congenital cytomegalovirus","volume":"93","author":"Gallach","year":"2020","journal-title":"An. De Pediatr\u00eda"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Alifieraki, S., Payne, H., Hathaway, C., Tan, R.W.Y., and Lyall, H. (2022). Delays in diagnosis and treatment initiation for congenital cytomegalovirus infection\u2013Why we need universal screening. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.988039"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.spen.2017.03.014","article-title":"A Quiet Disease With Loud Manifestations","volume":"26","author":"Moresco","year":"2018","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3928\/01913913-20120710-03","article-title":"Ophthalmological findings in congenital cytomegalovirus infection: When to screen, when to treat?","volume":"49","author":"Ghekiere","year":"2012","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/INF.0000000000001599","article-title":"Long-term Visual and Ocular Sequelae in Patients With Congenital Cytomegalovirus Infection","volume":"36","author":"Jin","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00467-006-0051-4","article-title":"Cytomegalovirus-related congenital nephrotic syndrome with diffuse mesangial sclerosis","volume":"21","author":"Besbas","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3476(09)90017-8","article-title":"Diabetes insipidus associated with symptomatic congenital cytomegalovirus infection","volume":"122","author":"Mena","year":"1993","journal-title":"J. Pediatr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0022-3476(78)80373-4","article-title":"Graves disease following congenital cytomegalovirus infection","volume":"92","author":"Salisbury","year":"1978","journal-title":"J. Pediatr."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","article-title":"Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management","volume":"36","author":"Luck","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1007\/s00330-021-07776-2","article-title":"Brain MRI findings in newborns with congenital cytomegalovirus infection: Results from a large cohort study","volume":"31","author":"Keymeulen","year":"2021","journal-title":"Eur. Radiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.braindev.2013.04.001","article-title":"Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection","volume":"36","author":"Capretti","year":"2014","journal-title":"Brain Dev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpeds.2013.03.014","article-title":"Clinical, biochemical, and neuroimaging findings predict long-term neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection","volume":"163","author":"Alarcon","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pd.5591","article-title":"The MRI spectrum of congenital cytomegalovirus infection","volume":"40","author":"Diogo","year":"2020","journal-title":"Prenat. Diagn."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/INF.0000000000001974","article-title":"Neuroimaging Profiles and Neurodevelopmental Outcome in Infants With Congenital Cytomegalovirus Infection","volume":"37","author":"Giannattasio","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.braindev.2007.12.004","article-title":"Epilepsy in patients with congenital cytomegalovirus infection","volume":"30","author":"Suzuki","year":"2008","journal-title":"Brain Dev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/archdischild-2021-323380","article-title":"Vestibular and balance dysfunction in children with congenital CMV: A systematic review","volume":"107","author":"Shears","year":"2022","journal-title":"Arch. Dis. Childhood. Fetal Neonatal Ed."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00431-022-04375-1","article-title":"Olfactory function in congenital cytomegalovirus infection: A prospective study","volume":"181","author":"Lazarini","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.2014-1173","article-title":"Hearing loss and congenital CMV infection: A systematic review","volume":"134","author":"Goderis","year":"2014","journal-title":"Pediatrics"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e20193945","DOI":"10.1542\/peds.2019-3945","article-title":"Vestibular, Gaze, and Balance Disorders in Asymptomatic Congenital Cytomegalovirus Infection","volume":"147","author":"Pinninti","year":"2021","journal-title":"Pediatrics"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e1938","DOI":"10.1002\/rmv.1938","article-title":"Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic review","volume":"25","author":"Bartlett","year":"2017","journal-title":"Rev. Med. Virol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Kimberlin, D.W., Banerjee, R., Barnett, E.D., Lynfield, R., and Sawyer, M.H. (2024). Cytomegalovirus Infection. Red Book: 2024\u20132027 Report of the Committee on Infectious Diseases, American Academy of Pediatrics.","DOI":"10.1542\/9781610027373"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"n1212","DOI":"10.1136\/bmj.n1212","article-title":"Congenital cytomegalovirus infection","volume":"373","author":"Pesch","year":"2021","journal-title":"BMJ"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3345\/cep.2022.01032","article-title":"Treatment of congenital cytomegalovirus infection","volume":"66","author":"Shim","year":"2022","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/AOG.0000000000005840","article-title":"Evaluation and Management of Congenital Cytomegalovirus Infection","volume":"145","author":"Coskun","year":"2025","journal-title":"Obstet. Gynecol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Sohmer, J., Lobaina, D., Faliv, M., Lotharius, K., Jhumkhawala, V., Fridman, S., Follin, T., and Sacca, L. (2025). Assessing the Scope of Evidence-Based Interventions and Policy Mobilization Efforts on CMV Infection Prevention in U.S. Pregnant Women: A Scoping Review. Women, 5.","DOI":"10.3390\/women5020011"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Rybak-Krzyszkowska, M., G\u00f3recka, J., Huras, H., Massalska-Wolska, M., Sta\u015bkiewicz, M., Gach, A., Kondracka, A., Staniczek, J., G\u00f3rczewski, W., and Borowski, D. (2023). Cytomegalovirus Infection in Pregnancy Prevention and Treatment Options: A Systematic Review and Meta-Analysis. Viruses, 15.","DOI":"10.3390\/v15112142"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Mu\u00f1oz, M.F., Mart\u00edn-Mart\u00edn, C., Kovacheva, K., Olivares, M.E., Izquierdo, N., P\u00e9rez-Romero, P., and Garc\u00eda-R\u00edos, E. (2024). Hygiene-based measures for the prevention of cytomegalovirus infection in pregnant women: A systematic review. BMC Pregnancy Childbirth, 24.","DOI":"10.1186\/s12884-024-06367-5"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpeds.2004.05.041","article-title":"Prevention of child-to-mother transmission of cytomegalovirus among pregnant women","volume":"145","author":"Adler","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Cannon, M.J., and Davis, K.F. (2005). Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health, 5.","DOI":"10.1186\/1471-2458-5-70"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e2022059895","DOI":"10.1542\/peds.2022-059895","article-title":"Considering Antiviral Treatment to Preserve Hearing in Congenital CMV","volume":"151","author":"Lanzieri","year":"2023","journal-title":"Pediatrics"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2009.09.003","article-title":"Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital","volume":"46","author":"Picone","year":"2009","journal-title":"J. Clin. Virol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcv.2012.06.022","article-title":"Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France","volume":"55","author":"Cordier","year":"2012","journal-title":"J. Clin. Virol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ebiom.2015.08.003","article-title":"Prevention of Primary Cytomegalovirus Infection in Pregnancy","volume":"2","author":"Revello","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Calvert, A., Vandrevala, T., Parsons, R., Barber, V., Book, A., Book, G., Carrington, D., Greening, V., Griffiths, P., and Hake, D. (2021). Changing knowledge, attitudes and behaviours towards cytomegalovirus in pregnancy through film-based antenatal education: A feasibility randomised controlled trial of a digital educational intervention. BMC Pregnancy Childbirth, 21.","DOI":"10.1186\/s12884-021-03979-z"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Bartnik, P., Bender, A., Kacperczyk-Bartnik, J., Ciebiera, M., Urban, A., Sienko, A., Bilir, E., Romejko-Wolniewicz, E., and Sie\u0144ko, J. (2024). Awareness of Pregnant Patients about Congenital Cytomegalovirus Infection-A Semi-Systematic Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13092586"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Hussami, D., Sartori, P., Martinez de Tejada, B., Farin, A., Rieder, W., Rouiller, S., Robyr, R., Muller Brochut, A.-C., Grant, G., and Ben Ali, N. (2025). Awareness and knowledge of cytomegalovirus infection among pregnant women in French-speaking Switzerland. BMC Pregnancy Childbirth, 25.","DOI":"10.1186\/s12884-025-07537-9"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jogc.2021.05.015","article-title":"Guideline No. 420: Cytomegalovirus Infection in Pregnancy","volume":"43","author":"Boucoiran","year":"2021","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Billette de Villemeur, A., Tattevin, P., and Salmi, L.R. (2020). Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: A methodological appraisal and decision analysis. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05139-8"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jcv.2014.10.002","article-title":"Cytomegalovirus DNAemia in pregnant women","volume":"61","author":"Revello","year":"2014","journal-title":"J. Clin. Virol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14787210.2021.1846521","article-title":"Hyperimmunoglobulin therapy for the prevention and treatment of congenital cytomegalovirus: A systematic review and meta-analysis","volume":"19","author":"Ghozy","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Karofylakis, E., Thomas, K., Kavatha, D., Galani, L., Tsiodras, S., Giamarellou, H., Papaevangelou, V., and Antoniadou, A. (2024). Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study. Viruses, 16.","DOI":"10.3390\/v16081241"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Schirwani-Hartl, N., Palmrich, P., Haberl, C., Perkmann-Nagele, N., Kiss, H., Berger, A., Rittenschober-B\u00f6hm, J., Kasprian, G., Kienast, P., and Khalil, A. (2023). Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy. J. Clin. Med., 12.","DOI":"10.3390\/jcm12216776"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.19164","article-title":"Prevention\u2009of\u2009maternal-fetal\u2009transmission\u2009of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration","volume":"53","author":"Kagan","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/infdis\/jiz493","article-title":"Advances in the Development of Therapeutics for Cytomegalovirus Infections","volume":"221","author":"Acosta","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: A randomised, double-blind, placebo-controlled trial","volume":"396","author":"Pardo","year":"2020","journal-title":"Lancet"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","article-title":"The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis","volume":"230","author":"Chatzakis","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/uog.26226","article-title":"Cost-effectiveness of screening and valacyclovir-based treatment strategies for first-trimester cytomegalovirus primary infection in pregnant women in France","volume":"62","author":"Lepers","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"462-e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Ghout","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2025.02.009","article-title":"Universal screening and valacyclovir for first trimester primary cytomegalovirus: A cost-effectiveness analysis","volume":"233","author":"Dzubay","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","volume":"37","author":"Plotkin","year":"2019","journal-title":"Vaccine"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0264-410X(00)00377-7","article-title":"Encouraging prospects for immunisation against primary cytomegalovirus infection","volume":"19","author":"Griffiths","year":"2001","journal-title":"Vaccine"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Lankina, A., Raposo, M., Hargreaves, A., Atkinson, C., Griffiths, P., and Reeves, M.B. (2025). Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV\u2019s Immunological Achilles\u2019 Heel. Vaccines, 13.","DOI":"10.3390\/vaccines13050435"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jiz464","article-title":"Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity","volume":"221","author":"Britt","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.jcv.2009.10.003","article-title":"CMV vaccine trial endpoints","volume":"46","author":"Griffiths","year":"2009","journal-title":"J. Clin. Virol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.vaccine.2018.07.056","article-title":"Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response","volume":"36","author":"Cui","year":"2018","journal-title":"Vaccine"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/infdis\/jiz428","article-title":"Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease","volume":"221","author":"Nelson","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e182317","DOI":"10.1172\/JCI182317","article-title":"A vaccine against cytomegalovirus: How close are we?","volume":"135","author":"Permar","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Choi, K.Y., and McGregor, A. (2021). A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary. Viruses, 13.","DOI":"10.3390\/v13081467"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Bialas, K.M., and Permar, S.R. (2016). The March towards a Vaccine for Congenital CMV: Rationale and Models. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005355"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1111\/1469-0691.12449","article-title":"Cytomegalovirus vaccine: Phase II clinical trial results","volume":"20","author":"Rieder","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine Prevention of Maternal Cytomegalovirus Infection","volume":"360","author":"Pass","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41467-023-36683-x","article-title":"The cytomegalovirus gB\/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread","volume":"14","author":"Gomes","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"eabb3611","DOI":"10.1126\/scitranslmed.abb3611","article-title":"Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB\/MF59 vaccine in humans","volume":"12","author":"Jenks","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ebiom.2019.11.005","article-title":"Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation","volume":"50","author":"Baraniak","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2450045","DOI":"10.1080\/21645515.2025.2450045","article-title":"The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)","volume":"21","author":"Akingbola","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1093\/infdis\/jiae114","article-title":"Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial","volume":"230","author":"Fierro","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Chiavarini, M., Genga, A., Ricciotti, G.M., D\u2019Errico, M.M., and Barbadoro, P. (2025). Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials. Vaccines, 13.","DOI":"10.3390\/vaccines13010085"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"343.e1","DOI":"10.1016\/j.jtct.2022.03.003","article-title":"CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation","volume":"28","author":"Rashidi","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/M19-2511","article-title":"Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: A phase 2, randomized clinical trial","volume":"172","author":"Aldoss","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_194","unstructured":"City of Hope Medical Center (2025, May 12). Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04060277."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(23)00343-2","article-title":"Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: A double-blind, randomised, placebo-controlled, phase 2b trial","volume":"23","author":"Das","year":"2023","journal-title":"Lancet. Infect. Dis."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/jiz141","article-title":"Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects","volume":"220","author":"Adler","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Murata, S., Oshima, N., Iwasa, T., Fukao, Y., and Sawata, M. (2023). Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study. Antibodies, 12.","DOI":"10.3390\/antib12010022"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/infdis\/jiaa121","article-title":"A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus","volume":"225","author":"Schwendinger","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_199","unstructured":"Hookipa Biotech GmbH (2018). A Randomized, Placebo-Controlled, Phase 2 Study of HB-101, a Bivalent Cytomegalovirus (CMV) Vaccine, in CMV-Seronegative Recipient (R\u2212) Patients Awaiting Kidney Transplantation From Living CMV-Seropositive Donors (D+), Hookipa Biotech GmbH."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbmt.2008.07.014","article-title":"Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation","volume":"14","author":"Bao","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Perotti, M., Marcandalli, J., Demurtas, D., Sallusto, F., and Perez, L. (2020). Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1009169"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Abusalah, M.A.H., Chopra, H., Sharma, A., Mustafa, S.A., Choudhary, O.P., Sharma, M., Dhawan, M., Khosla, R., Loshali, A., and Sundriyal, A. (2023). Nanovaccines: A game changing approach in the fight against infectious diseases. Biomed. Pharmacother., 167.","DOI":"10.1016\/j.biopha.2023.115597"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"100351","DOI":"10.1016\/j.microb.2025.100351","article-title":"Virus-like particles: Innovative strategies for combatting emerging and re-emerging viral threats","volume":"7","author":"Laxmi","year":"2025","journal-title":"Microbe"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.vaccine.2023.12.019","article-title":"An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study","volume":"42","author":"Langley","year":"2024","journal-title":"Vaccine"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"S765","DOI":"10.1093\/ofid\/ofy229.2192","article-title":"LB18. An Enveloped Virus-like Particle (eVLP) Cytomegalovirus (CMV) Vaccine Is Immunogenic and Safe: Results of a First-in-Humans Study","volume":"5","author":"Gantt","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Eslami, M., Fadaee Dowlat, B., Yaghmayee, S., Habibian, A., Keshavarzi, S., Oksenych, V., and Naderian, R. (2025). Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity. Vaccines, 13.","DOI":"10.3390\/vaccines13060588"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1093\/infdis\/jiz523","article-title":"Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines","volume":"221","author":"Krause","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/cid\/ciad179","article-title":"Can We Prevent Congenital Infection by Cytomegalovirus?","volume":"76","author":"Plotkin","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1093\/infdis\/jiz448","article-title":"Preventing Infection by Human Cytomegalovirus","volume":"221","author":"Plotkin","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"e00268-17","DOI":"10.1128\/CVI.00268-17","article-title":"Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2353\/ajpath.2006.050482","article-title":"Maternal Antibodies Enhance or Prevent Cytomegalovirus Infection in the Placenta by Neonatal Fc Receptor-Mediated Transcytosis","volume":"168","author":"Maidji","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/infdis\/jiac131","article-title":"Derisking Human Cytomegalovirus Vaccine Clinical Development in Relevant Preclinical Models","volume":"226","author":"Permar","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"e00207-25","DOI":"10.1128\/jvi.00207-25","article-title":"Replication-deficient whole-virus vaccines against cytomegalovirus induce protective immunity in a guinea pig congenital infection model","volume":"99","author":"Schleiss","year":"2025","journal-title":"J. Virol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-007-0073-y","article-title":"Rhesus CMV: An emerging animal model for human CMV","volume":"197","author":"Powers","year":"2008","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Singh, T., Otero, C.E., Li, K., Valencia, S.M., Nelson, A.N., and Permar, S.R. (2020). Vaccines for Perinatal and Congenital Infections\u2014How Close Are We?. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.00569"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1073\/pnas.1511526112","article-title":"Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission","volume":"112","author":"Bialas","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.cmi.2022.05.034","article-title":"Comparative clinical manifestations and immune effects of cytomegalovirus infections following distinct types of immunosuppression","volume":"28","author":"Ong","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Scarpini, S., Morigi, F., Betti, L., Dondi, A., Biagi, C., Lanari, M., Scarpini, S., Morigi, F., Betti, L., and Dondi, A. (2021). Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice. Vaccines, 9.","DOI":"10.3390\/vaccines9060551"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Esposito, S., Chiopris, G., Messina, G., D\u2019Alvano, T., Perrone, S., and Principi, N. (2021). Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art. Vaccines, 9.","DOI":"10.3390\/vaccines9050523"},{"key":"ref_220","unstructured":"CDC (2025, June 20). Vaccines and Preventable Diseases. Administering HPV Vaccine. Dosage and Schedule, Available online: https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/administration.html#:~:text=HPV%20vaccines%20are%20administered%20as,years%2C%20and%20for%20immunocompromised%20persons."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"e002522","DOI":"10.1136\/bmjph-2024-002522","article-title":"Health and economic evaluation of cytomegalovirus vaccination strategy among young women in China: A modelling study","volume":"3","author":"Ge","year":"2025","journal-title":"BMJ Public Health"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/929\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:36:21Z","timestamp":1760034981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":221,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["vaccines13090929"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13090929","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]}}}